1. Home
  2. GLDD vs PHAT Comparison

GLDD vs PHAT Comparison

Compare GLDD & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Great Lakes Dredge & Dock Corporation

GLDD

Great Lakes Dredge & Dock Corporation

HOLD

Current Price

$13.37

Market Cap

814.6M

Sector

Industrials

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$17.50

Market Cap

942.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GLDD
PHAT
Founded
1890
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
814.6M
942.6M
IPO Year
2006
2019

Fundamental Metrics

Financial Performance
Metric
GLDD
PHAT
Price
$13.37
$17.50
Analyst Decision
Strong Buy
Analyst Count
0
6
Target Price
N/A
$17.33
AVG Volume (30 Days)
400.7K
870.6K
Earning Date
11-04-2025
10-30-2025
Dividend Yield
N/A
N/A
EPS Growth
36.27
N/A
EPS
1.19
N/A
Revenue
$834,599,000.00
$147,190,000.00
Revenue This Year
$12.71
$220.37
Revenue Next Year
$4.77
$83.14
P/E Ratio
$11.22
N/A
Revenue Growth
12.53
460.30
52 Week Low
$7.51
$2.21
52 Week High
$14.02
$18.31

Technical Indicators

Market Signals
Indicator
GLDD
PHAT
Relative Strength Index (RSI) 55.64 66.74
Support Level $13.28 $16.77
Resistance Level $13.60 $18.31
Average True Range (ATR) 0.36 0.88
MACD -0.06 0.26
Stochastic Oscillator 43.10 79.95

Price Performance

Historical Comparison
GLDD
PHAT

About GLDD Great Lakes Dredge & Dock Corporation

Great Lakes Dredge & Dock Corp is a provider of dredging services in the United States. The Company is also fully engaged in expanding its core business into the offshore energy industry. Dredging involves the enhancement or preservation of the navigability of waterways or the protection of shorelines through the removal or replenishment of soil, sand, or rock. Company work generally is to performed in coastal waterways and deep water ports. Its project portfolio includes Coastal Restoration, Coastal Protection, Ports and Harbors, International, and Inland Dredging.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: